NUF Price sensitive 21 May 2025, 8:19 AM

Nufarm HY25 results presentation

Nufarm Ltd

Nufarm reports HY25 results

Key points

  • Strong recovery in Crop Protection with actions to improve returns and free cash flow
  • Seed Technologies and new/emerging technologies performing well
  • Clear actions to improve profitability, deliver higher returns and de-leverage the balance sheet

Full summary

Nufarm Limited (ASX: NUF) has reported its HY25 results, showcasing a strong recovery in its Crop Protection business, solid performances across Seed Technologies and new/emerging technologies, and clear actions to improve profitability, deliver higher returns and de-leverage the balance sheet. The company's Crop Protection segment benefited from normalising market conditions and an improved cost of goods position, driving a 4% increase in revenue. Seed Technologies and new/emerging technologies, including hybrid seeds, omega-3, and bioenergy, also contributed to the overall performance. Nufarm has implemented measures to improve profitability, such as actions to reduce net debt and leverage, which was impacted by lower omega-3 earnings and foreign exchange translation. The company's net working capital improved by around $100 million year-on-year, with a focus on inventory management. Nufarm's capital expenditure increased to support Seed Technologies, plant health and safety, and growth opportunities, with expectations of a moderation in requirements from the second half of FY25 and into FY26. The company remains well-positioned, but acknowledges several uncertainties that could impact the second half of the year.

Guidance

Nufarm expects a 15% year-on-year decline in its omega-3 business in FY25 due to market conditions.

Outlook

Nufarm is well-positioned for the second half of FY25, but acknowledges several uncertainties that could impact the company's performance, including market conditions, regulatory decisions, operational changes, and global economic and geopolitical factors.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in